Theratechnologies THTX

$ 1.77 6.71%

Annual report 2023
added 12-21-2024

Theratechnologies Balance Sheet 2011-2024 | THTX

Annual Balance Sheet Theratechnologies

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	40.1 M	26.6 M	10.2 M	6.74 M	9.26 M	2.28 M	13.3 M	-900 K	-1.5 M	-2.5 M
Long Term Debt	-	-	-	52.4 M	55.3 M	49.2 M	3.36 M	6.59 M	9.26 M	10.1 M	-	-	-
Long Term Debt Current	421 K	476 K	463 K	425 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	55 M	55.6 M	49.2 M	3.36 M	7.88 M	9.78 M	10.1 M	1.6 M	7.3 M	4.9 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	98.6 M	116 M	101 M	96.9 M	2.95 M	76.1 M	24.6 M	19.3 M	22.3 M	18.6 M	6 M	13.7 M	16.2 M
Deferred Revenue	-	-	-	50 K	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-300 M	-277 M	-265 M	-223 M	-208 M	-208 M	-211 M	-255 M	-268 M	-248 M
Total Assets	77.8 M	93.3 M	119 M	100 M	2.95 M	111 M	56.5 M	39.2 M	37.1 M	24.5 M	23.4 M	36.5 M	51.9 M
Cash and Cash Equivalents	34.1 M	23.9 M	20.4 M	12.7 M	28.7 M	39 M	-	-	-	-	-	-	-
Book Value	-20.9 M	-22.6 M	17.8 M	3.22 M	-	35 M	31.9 M	19.9 M	14.8 M	5.91 M	17.4 M	22.8 M	35.7 M
Total Shareholders Equity	-	-	-	3.22 M	24.8 M	35 M	33.4 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Theratechnologies

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	2.06 M	-	-	-	2.56 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	56.4 M	-	-	-	55 M	-	-	-	55.6 M	-	-	-	49.2 M	-	-	-	3.52 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	101 M	-	-	-	96.9 M	-	-	-	2.95 M	-	-	-	76.1 M	-	-	-	25.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-335 M	-	-	-	-300 M	-	-	-	-	-	-	-	-265 M	-	-	-	-261 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	119 M	-	-	-	100 M	-	-	-	2.95 M	-	-	-	111 M	-	-	-	59.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	20.4 M	-	-	-	12.7 M	-	-	-	28.7 M	-	-	-	39 M	-	-	-	1.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	17.8 M	-	-	-	3.22 M	-	-	-	-	-	-	-	35 M	-	-	-	33.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	17.8 M	-	-	-	3.22 M	-	-	-	24.8 M	-	-	-	35 M	-	-	-	33.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency